English
  • Dabrafenib

    Dabrafenib

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Dabrafenib      
    inquirydetail
  • Aprocitentan

    Aprocitentan

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Aprocitentan      
    inquirydetail
  • Etrasimod

    Etrasimod

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Etrasimod Ulceratuve Colitis(UC) Arena(Pfizer)  Mar.05,2030
    inquirydetail
  • Tirzepatide

    Tirzepatide

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Tirzepatide Type 2 diabetes, lose weight Eli Lilly  Jan.05,2036
    inquirydetail
  • Semaglutide

    Semaglutide

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Semaglutide Type2 diabetes,lose weight Novo Nordisk  Dec.05,2031
    inquirydetail
  • Oteseconazole

    Oteseconazole

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Oteseconazole Reduce the incidence rate of

    recurrent vulvovaginal candidiasis

    		 MycoviaPharmaceuticals  Apr.22,2031
    inquirydetail
  • Finerenone

    Finerenone

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Finerenone Diabetic Nephropathy Bayer  Apr.12,2029
    inquirydetail
  • Vibegron

    Vibegron

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Vibegron OAB Urovant  Dec.01,2030
    inquirydetail
  • Capivasertib

    Capivasertib

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Capivasertib breast cancer AstraZeneca  Mar.10.2030
    inquirydetail
  • Resmetirom

    Resmetirom

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Resmetirom NASH Roche  Sep.12,2026
    inquirydetail
  • Darolutamide

    Darolutamide

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Darolutamide prostatic cancer treatment Bayer  Mar. 25,2033
    inquirydetail
  • Upadacitinib

    Upadacitinib

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Upadacitinib Atopic Dermatitis ABBVIE INC  Dec.01,2030
    inquirydetail
123456 Next > >> Page 1 / 6